期刊文献+

云南省艾滋病患者分离新生隐球菌的药物敏感性检测与分析 被引量:9

Detection and analysis of antimicrobial susceptibility of Cryptococcus neoformans isolated from patients with acquired immunodeficiency syndrome in Yunnan Province
下载PDF
导出
摘要 目的了解云南省艾滋病患者分离新生隐球菌的药物敏感性情况。方法采用比色微量稀释法,对2007年8月—2018年7月云南省传染病医院住院艾滋病患者标本分离的304株新生隐球菌进行药敏试验,检测6种常用抗隐球菌药物的敏感性。结果药敏结果显示:两性霉素B、5-氟胞嘧啶、氟康唑、伏立康唑、伊曲康唑及泊沙康唑MIC_(50)分别为1、2、4、0.03、0.06、0.12μg/mL,MIC_(90)分别为1、4、8、0.06、0.12、0.25μg/mL,几何均数分别为0.75、2.32、3.28、0.039、0.053、0.09μg/mL。在6种抗真菌药物中,新生隐球菌对伏立康唑和两性霉素B的耐药率为1.32%,5-氟胞嘧啶的耐药率为0.33%,未发现对伊曲康唑和氟康唑产生耐药的菌株。结论云南省艾滋病患者分离的新生隐球菌对不同药物敏感性有差异,可为临床选药提供参考。 Objective To investigate antimicrobial susceptibility of Cryptococcus neoformans(C.neoformans)isolated from patients with acquired immunodeficiency syndrome(AIDS)in Yunnan Province.Methods 304 strains of C.neoformans isolated from AIDS patients in Yunnan Infectious Diseases Hospital between August 2007 and July 2018 were performed antimicrobial susceptibility testing by colorimetric microdilution method,susceptibility to 6 commonly used anti-cryptococcal agents was detected.Results Antimicrobial susceptibility testing results showed that MIC 50 of amphotericin B,5-fluorocytosine,fluconazole,voriconazole,itraconazole,and posaconazole were 1,2,4,0.03,0.06,and 0.12μg/mL respectively,and the MIC 90 were 1,4,8,0.06,0.12,and 0.25μg/mL respectively,with geometric mean values of 0.75,2.32,3.28,0.039,0.053,and 0.09μg/mL respectively.Among 6 antifungal agents,resistance rate of C.neoformans to voriconazole and amphotericin B was 1.32%,and to 5-fluorocytosine was 0.33%,no strain was found to be resistant to itraconazole and fluconazole.Conclusion C.neoformans isolated from AIDS patients in Yunnan Province have different susceptibility to different antimicrobial agents,which can provide reference for clinical antimicrobial choice.
作者 樊红丽 高丽 毛小琴 张米 李正伦 杨翠先 FAN Hong-li;GAO Li;MAO Xiao-qin;ZHANG Mi;LI Zheng-lun;YANG Cui-xian(Department of Clinical Laboratory,AIDS Care Center,Yunnan Provincial Infectious Disease Hospital,Kunming 650301,China;Medical School of Kunming University of Science and Technology,Kunming 650500,China;Department of Clinical Laboratory,First People’s Hospital of Yunnan Province,Kunming 650032,China)
出处 《中国感染控制杂志》 CAS CSCD 北大核心 2019年第4期340-343,共4页 Chinese Journal of Infection Control
基金 2017年度云南省医疗卫生单位内设研究机构科研项目(2017NS122)
关键词 艾滋病 人类免疫缺陷病毒 新生隐球菌 药敏试验 acquired immunodeficiency syndrome human immunodeficiency virus Cryptococcus neoformans antimicrobial susceptibility testing
  • 相关文献

参考文献7

二级参考文献30

  • 1杨怀琴,冯泽甫.新型隐球菌性脑膜炎12例诊治体会[J].实用神经疾病杂志,2005,8(1):37-38. 被引量:4
  • 2郭爱华,胡学强.新型隐球菌颅内感染101例临床特点及诊断[J].中华神经科杂志,2005,38(7):445-447. 被引量:22
  • 3梁欣,罗光汉.新型隐球菌性脑膜炎的治疗进展[J].国外医学(流行病学.传染病学分册),2005,32(4):249-251. 被引量:36
  • 4曹晖.关于深部真菌感染的相关研究进展[J].医学综述,2005,11(10):946-947. 被引量:34
  • 5王爱霞,王福生,王清玥,王健,冯铁建,卢洪洲,孙洪清,孙永涛,叶寒辉,李太生,李兴旺,刘正印,邢玉兰,何云,汪宁,吴昊,吴南屏,张福杰,周曾全,宫恩聪,赵红心,赵敏,唐小平,徐莲芝,徐小元,曹韵贞,康来仪,蒋岩,蔡卫平,樊庆泊,潘孝彰.艾滋病诊疗指南[J].中华传染病杂志,2006,24(2):133-144. 被引量:630
  • 62006年我国艾滋病防治工作稳步推进[J].中国艾滋病性病,2007,13(2):99-100. 被引量:26
  • 7[1]National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of yeasts: A pproved standard M27-A Wayne[S]. Pa NCCLS, 1997.
  • 8[2]Makimura K, Sudo T, Kudo M, et al. Development of reference procedures for broth microdilution antifungal susceptibility testing of yeasts with standardized endpoint determination[J]. Microbiol Immunol, 1998, 42(1): 55-59.
  • 9[3]Nguyen MH, Christine Y YU. In Vitro comparative efficacy of voriconazle and itracohazole gainst fluconazole-susceptible and Resistant cryptococcus neoformans Isolates[J]. Antimicrob Agents Chemother, 1998 42(2):471-2.
  • 10[4]Martin MV, Yates J, Hitchcock CA. Comparison of voriconazole and itraconazole in prevention and treatment of aspergillus fumigatus endocarditis in guinea pigs[J]. Antimicrob Agents Chemother, 1997, 41(1): 13-16.

共引文献50

同被引文献54

引证文献9

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部